PWP
WST icon

Personal Wealth Partners’s West Pharmaceutical WST Stock Holding History

Personal Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4
Closed -$1K – 626
2019
Q4 		$1K Hold
4
– – ﹤0.01% 484
2019
Q3 		$1K Buy
+4
New +$551 ﹤0.01% 497

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Personal Wealth Partners's WST Position: Q1 2020 in Review

Personal Wealth Partners sold out of West Pharmaceutical (WST) in Q1 2020, closing a stake of 4 shares — an estimated $1K sold.

Personal Wealth Partners first reported a position in WST in Q3 2019 and held it in 2 quarters. The position peaked at $1K in Q4 2019. 468 funds tracked by Wall St. Rank hold WST as of Q1 2020.

  • Personal Wealth Partners reported no remaining West Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Personal Wealth Partners sold 4 West Pharmaceutical shares in Q1 2020, an estimated $1K.
  • Personal Wealth Partners first reported a position in West Pharmaceutical in Q3 2019 and held it in 2 quarters.
  • Personal Wealth Partners's West Pharmaceutical position peaked at $1K in Q4 2019.
  • 468 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2020.

Based on Personal Wealth Partners's 13F filing for Q1 2020, filed 7 May 2020.